United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 22, 2026 · Filed Apr 23, 2026

On Apr 22, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$576.57 for US$5.48M under a trading plan, leaving 40,513 shares. Filed Apr 23, 2026 (Form 4).

Sold
9,500 shares
Price
US$576.57 average (US$572.48 to US$580.06)
Value
US$5.48M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 22, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 22, 2026Common StockSale523US$572.4849,490Direct
Apr 22, 2026Common StockSale1,644US$574.0647,846Direct
Apr 22, 2026Common StockSale736US$574.8647,110Direct
Apr 22, 2026Common StockSale1,410US$575.9945,700Direct
Apr 22, 2026Common StockSale1,707US$576.9843,993Direct
Apr 22, 2026Common StockSale1,781US$578.1142,212Direct
Apr 22, 2026Common StockSale1,099US$579.0841,113Direct
Apr 22, 2026Common StockSale600US$580.0640,513Direct

Source

View original at SEC

Related